Two Sigma Securities, LLC Sio Gene Therapies Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.25 - $0.73 $2,729 - $7,970	-10,918 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $12,956 - $34,628	-23,557 Reduced 68.33%	10,918 $7,000
Q4 2021 Feb 14, 2022	BUY	$1.29 - $2.36 $27,624 - $50,537	21,414 Added 163.95%	34,475 $44,000
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $23,640 - $35,264	13,061 New	13,061 $28,000
Q1 2021 May 17, 2021	SELL	$2.34 - $3.44 $124,366 - $182,829	-53,148 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $101,512 - $299,223	53,148 New	53,148 $148,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.